2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

Clinical trial NCT05155098 · COMPLETED

Trial details

NCT number: NCT05155098
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate to Severe Plaque Psoriasis Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondyloarthritis

Start date: 2022-03-25
Primary completion: 2025-08-20
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.